Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,441
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Seattle WA, Los Angeles CA, Aurora CO, Lone Tree CO,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase1, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: Seattle WA, San Francisco CA, Stanford CA, Duarte CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase1, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Seattle WA, Edmonds WA, Vancouver WA, Portland OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Seattle WA, Portland OR, Boise ID, San Francisco CA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 65+
Code: NCT04889872
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
for
Extensive-Stage Small Cell Lung Cancer
Location: Seattle WA, Edmonds WA, Bismarck ND, Albuquerque NM,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06646276
Phase3, Recruiting
ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
for
Estrogen Receptor-Positive, HER2-Negative,
Location: Seattle WA
Sponsor: EnhancedBio USA Inc.
Sex: All
Age: 18+
Code: NCT04669587
Phase1, Phase2, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
for
Non-Small Cell Lung Cancer
Location: Seattle WA, Spokane WA, Eugene OR, Sacramento CA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT05899608
Phase3, Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
for
Extensive Stage Small Cell Lung Cancer
Location: Seattle WA, Los Angeles CA, Sioux Falls SD, Chicago IL,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06598306
Phase1, Recruiting
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
for
Colorectal Neoplasms, Gastrointestinal Neoplasms
Location: Seattle WA, Aurora CO, Tucson AZ, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06663319
Phase1, Recruiting
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer